Back to 
Axiom Investors LLC
Axiom Investors LLC
HALO
Showing 0 of 13 quarters
Position history for Axiom Investors LLC's holdings in Halozyme Therapeutics, Inc.
No. Axiom Investors exited its HALO (Halozyme Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 31,715 shares worth $1.2M. Axiom Investors first reported HALO in Q4 2020 and held it in 12 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.